Yahoo Finance

Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption

HOUSTON, April 07, 2026 (GLOBE NEWSWIRE)-- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and ...
FoodNavigator

Automated test speeds up contamination enumeration

BioMérieux, a France-based in vitro diagnostics firm, claims its new Tempo EB deliversan Enterobacteriaceae count, including confirmation, in as little as 22 hours. The traditional EN-ISO 21528-2 ...
The Hindu

Pre-test for Census first phase to be held from November 10

The pre-test for the first phase of Population Census 2027 will be conducted from November 10-30 in selected sample areas of all States and Union Territories, the Registrar General and Census ...
Finanznachrichten

Plus Therapeutics Inc.: Plus Therapeutics Receives AMA PLA Code for CNSide CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption

HOUSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and ...